NRAS and neoplasm: Molecularly, this patient’s tumor harbored an NRAS mutation, consistent with the MAPK-mutant LGSOC subtype that has been associated with micropapillary stromal invasion and poor survival based on a recent whole-exome sequencing analysis identifying molecular subcohorts (Supplementary Document S1)12.